Advanced search
Publication Cover
Journal of Medical Economics Volume 14, 2011 - Issue 1
Submit an article Journal homepage
1,516
Views
15
CrossRef citations to date
0
Altmetric
Original Article

The cost effectiveness of rapid-acting insulin aspart compared with human insulin in type 2 diabetes patients: an analysis from the Japanese third-party payer perspective

R.F. Pollock Ossian Health Economics and Communications GmbH, Basel, SwitzerlandCorrespondence[email protected]
,
W.J. Valentine Ossian Health Economics and Communications GmbH, Basel, Switzerland
,
T. Pilgaard Novo Nordisk A/S, Virum, Denmark
&
H. Nishimura Osaka Saiseikai Nakatsu Hospital, Osaka, Japan
Pages 36-46 | Accepted 15 Nov 2010, Published online: 31 Dec 2010

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Victoria K Brennan, Josephine Mauskopf, Ann D Colosia, Catherine Copley-Merriman, Bastian Hass & Roberto Palencia. (2015) Utility estimates for patients with Type 2 diabetes mellitus after experiencing a myocardial infarction or stroke: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 15:1, pages 111-123.
Read now

Articles from other publishers (14)

Marzieh Nosrati, Soroush Ahmadi Fariman, Parisa Saiyarsarai & Shekoufeh Nikfar. (2023) Pharmacoeconomic evaluation of insulin aspart and glargine in type 1 and 2 diabetes mellitus in Iran. Journal of Diabetes & Metabolic Disorders 22:1, pages 817-825.
Crossref
Anthony L McCall, David C Lieb, Roma Gianchandani, Heidemarie MacMaster, Gregory A Maynard, M Hassan Murad, Elizabeth Seaquist, Joseph I Wolfsdorf, Robin Fein Wright & Wojtek Wiercioch. (2023) Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism 108:3, pages 529-562.
Crossref
Mathew John, Deepa Gopinath & Tittu Oommen. (2020) Co-Formulations as the First Injectable in Type 2 Diabetes: A Review of Efficacy, Safety, and Implications in Clinical Practice. Dubai Diabetes and Endocrinology Journal 26:4, pages 139-151.
Crossref
Asrul Akmal Shafie, Chin Hui Ng, Yui Ping Tan & Nathorn Chaiyakunapruk. (2016) Systematic Review of the Cost Effectiveness of Insulin Analogues in Type 1 and Type 2 Diabetes Mellitus. PharmacoEconomics 35:2, pages 141-162.
Crossref
Helene von Bibra, Thorsten Siegmund, Iris Kingreen, Markus Riemer, Tibor Schuster & Petra-Maria Schumm-Draeger. (2016) Effects of analogue insulin in multiple daily injection therapy of type 2 diabetes on postprandial glucose control and cardiac function compared to human insulin: a randomized controlled long-term study. Cardiovascular Diabetology 15:1.
Crossref
George Dailey & Edward Wang. (2014) A Review of Cardiovascular Outcomes in the Treatment of People with Type 2 Diabetes. Diabetes Therapy 5:2, pages 385-402.
Crossref
Mie Kasai Azuma & Shunya Ikeda. (2014) Investigation of Evidence Sources for Health-Related Quality of Life in Cost-Utility Analysis of Pharmaceuticals in Japan. Value in Health Regional Issues 3, pages 190-196.
Crossref
Tessa Kennedy-Martin, Beth D. Mitchell, Kristina S. Boye, Wen Chen, Bradley H. Curtis, Jennifer A. Flynn, Shunya Ikeda, Li Liu, Yen Huei Tarn, Bong-Min Yang & Emmanuel Papadimitropoulos. (2014) The Health Technology Assessment Environment in Mainland China, Japan, South Korea, and Taiwan—Implications for the Evaluation of Diabetes Mellitus Therapies. Value in Health Regional Issues 3, pages 108-116.
Crossref
Maria E. Mayorga, Odette S. Reifsnider, David M. Neyens, Mulugeta G. Gebregziabher & Kelly J. Hunt. (2013) Simulated Estimates of Pre-Pregnancy and Gestational Diabetes Mellitus in the US: 1980 to 2008. PLoS ONE 8:9, pages e73437.
Crossref
W. Rathmann & K. Kostev. (2012) Lower incidence of recorded cardiovascular outcomes in patients with type 2 diabetes using insulin aspart vs. those on human regular insulin: observational evidence from general practices. Diabetes, Obesity and Metabolism 15:4, pages 358-363.
Crossref
Gil R. Faria, John R. Preto & José Costa-Maia. (2013) Gastric Bypass is a Cost-Saving Procedure: Results from a Comprehensive Markov Model. Obesity Surgery 23:4, pages 460-466.
Crossref
Francisco Miguel G?mez Trujillo. (2012) Insulina aspart en pacientes de edad avanzada. Avances en Diabetolog?a 28, pages 39-42.
Crossref
red. (2012) Hinweise auf besseren kardiovaskul?ren Schutz des Diabetikers. CardioVasc 12:3, pages 68-68.
Crossref
RED. (2012) Hinweise auf besseren kardiovaskul?ren Schutz des Diabetikers. MMW - Fortschritte der Medizin 154:6, pages 34-35.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.